Indian vaccine giant SII warns of supply hit from U.S. raw materials export ban
A temporary U.S. ban on exports of critical raw materials could limit the production of coronavirus vaccines by companies such as the Serum Institute of India (SII), its chief executive said in a World Bank panel discussion on Thursday. SII, the world’s biggest vaccine maker, has licensed the AstraZeneca/Oxford University (AZN.L) product […]



